You
decide.
Awake or a zombie? Which to swallow?
Real deal or phoney polony?
The next video gaurantees nothing.
|
you have the power |
|
A cure for HIV AIDS was patented in 1993. Why haven't you heard about it? |
|
|
|
In December 2009 and January 2010 I handed out thousands of leaflets introducing people to the Bob Beck Protocol. With the introduction came my invitation for anyone who had been diagnosed as HIV positive to attend a free 3 week healing retreat. Hundreds of people admitted to me that they were HIV positive yet not a single individual took up my offer. I was dumbfounded.
Until I did the above I never realized the extent to which we live in a mind manipulated matrix. An acquaintance of mine who had some military background explained it to me. He said "Now you know how efficient the system is" and he was correct. People are largely unaware that they are living under mind control and "government" stands for "to govern mind" Occasionally some of us stumble out of the trance and assuming that you have stumbled out of the trance then here is your chance to boost your immune system like never before. These alternative electro medical technologies were developed in America by a brilliant professor of physics from the University of California, Dr Bob Beck, who many refer to as a genius and who worked for USA naval military, was involved with several government classified projects, improved things like sequential quantum integrating devices and most important for our interests contributed tremendously to the world by privately funding research into establishing concrete evidence to demonstrate the feasibility of bioelectric medical technology. Beck was governed by a "first, do no harm" approach so it's safe. Beck's advice is "take back your power".
|
|
You
Awake or a zombie? Which to swallow? Real deal or phoney polony? The next video gaurantees nothing.
|
|
The above video is one of several similar videos that are on the internet. Beck talks about his research and the machines that he developed. Before Beck experimented with his machines he was bald and after exposing himself to the electro currents and the colloidal silver his hair grew back to the amazement of his friends. Beck was also overweight and during his life he spent thousands of dollars on schemes to loose weight. His efforts, including liposuction, produced no permanent weight loss but without warning and to his great surprise and gratification and without any effort or diet changes the electro currents caused him to loose a remarkable 130 pounds. According
to Bob Beck and unbeknown to many there are viruses that rearrange
your body for their own convenience. Many of them do not want to
kill you and when it comes to why you can't loose your excess fat
then 30% of the time it's because there is an alien operating within
you which stimulates your appetite making you crave more food and
then it intercepts your digestive process and converts your food
intake into fat which it then stores throughout your body. While
such viruses inhabit your body then you will always exceed your
optimum weight resulting in you feeling sluggish and without energy. Welcome Bob Beck, goodbye virus and hello slim and sexy.
|
|
To see the notes that Beck refers to in the video CLICK HERE
|
|
For myself I have always considered myself to be healthy but small maladies have plagued me for decades and while they were not life threatening they were irksome. I started to manufacture Beck's machines for my own use and experimentation and subsequently the irritating maladies have vanished and the only explanation that I have is thank you to Bob Beck and I am exceedingly grateful for the privilege of knowing him through his works.
|
|
To make the blood electrifier yourself CLICK HERE |
|
BECK MACHINES for immortal blood. After witnessing amazing results some of my friends asked me to make machines for them and now I have decided to make them available to people who live in Cape Town so if you are getting frustrated with trying to build them yourself or if you are looking for a local supplier then I can help you with any or all of the following:
Blood electrifier Model One: Follows the Beck design to the letter and operates with three 9 volt batteries, stainless steel electrodes, cotton sleeves, adjustable armbands, natural sea salt.
Magnetic pulse generator: Connects to 230 volt mains supply with AC to 12 volt DC transformer, fires every second. Coil and output as per Bob Beck specifications. COLLOIDAL SILVER Forget about buying colloidal silver from a chemist @ R100 per litre. Save your money. It is an antibiotic but you don't have to pay someone else to get the stuff because you can make it yourself. It's legal, so you won't go to jail and it's easy. You can make as much colloidal silver as you want and it's so cheap when you make it yourself that you can spray the stuff onto your plants and give it to your pets. You can sell it to your friends or you can even give it to them for free.
999 silver wire: Electrical device for attaching to silver wire and instructions on how to make the best silver colloid using three 9 volt batteries. For the do-it-your-selfers, the silver wire is the most hard to come by. For any of the above email me at simprolaw@gmail.com Bob Beck Protocol booklet: CLICK HERE For the most part you can say goodbye to doctors and drug dealers. Constantly paying for your health is a thing of the past.
|
|
|
|
The Beck Protocol is by far the best way but not everyone has lots of thousands of rands to purchase these devices via the internet or a little cheaper through me. It's great if you can follow the Bob-Beck-Do-It-Yourself to build everything from scratch but it's not as easy as it looks as you may discover. BICARBONATE OF SODA For those who are in a "I want to be healthy but I'm in a strapped for cash situation" then there is an incredibly cheap substance that to a fair degree goes a long way and you can get it and use it immediately next time you do your grocery shopping. Some say it is not necessary to inject the chemical as the Italian Dr Simoncini prescribes. Try half a teaspoon of it with a glass of water first thing in the morning and same again before bed. A one week treatment will suffice and then after that occasionally when you feel like it. Whatever you decide then, and for your own safety, do a thorough search on the internet before you do anything and don't take my word for it. You owe it to yourself to check everything. My experience with drinking the soda in combination with the Bob Beck blood electrifier is that relief is delivered within 48 hours. Baking soda in water tastes terrible but it's cheap and easy for you to test and it makes a great bath salt for the next time you take a bath. Type in bicarbonate of soda and search the internet to see.
|
|
For those who find the above too naive to be taken seriously then you may be interested to read the report below. These are the notes that Bob Beck was unable to find that were handed out at a symposium that was presented after a team of medical doctors stumbled onto the healing properties of micro-currents. Theses papers were made to disappear using every dirty trick in the book including such low life tactics as going into libraries with razor blades but thanks to the efforts of Bob Beck and the internet they are now back in the public domain.
|
|
Biocompatible Electric Current Attentuates HIV Infectivity William D. Lyman, Ph.D., Professor Irwin R. Merkatz, M.D., Professor and Chairman Introduction The number of individuals infected by the human immunodeficiency virus type-1 (HIV) continues to increase on a world wide basis. A significant percentage, if not all, of these individuals will eventually develop the acquired immunodeficiency syndromes (AIDS). While horizontal transmission in the homosexual population may be contained or decreasing, heterosexual transmission and infection through contaminated blood supplies continues to increase. Additionally, vertical transmission from infected females to their fetuses is also on the rise with a resultant increase in the number of children with AIDS. New strategies, therefore, must be devised in order to limit more effectively the spread of this virus. In this regard, three principal approaches are currently being investigated. In order to decrease susceptibility to the consequences of infection, vaccines are being sought which will induce the production of protective antibodies. As treatment modalities, the use of soluble antagonists t block the receptor for HIV is being studied as are pharmacologic agents such as nucleic acid analogues which can interfere with the transcription of viral genomic sequences. Each of these systems has virtues and limitations, and to date none has proven completely efective. Because heat or light in combination with drugs and dyes
can inactivate viruses including HIV in vitro, others have suggested the
use of these forms of energy to treat AIDs patients. The results of
studies using heat have not been peer reviewed and are therefore
impossible to evaluate. The use of light with drugs
("photopheresis") appears to be efficacious, although this
treatment may be limited by drug toxicity and the potential long-term
effects of ultraviolet radiation on blood cell nucleic acids. Also, by its
nature, this last system may not be suitable for the treatment of tissue
associated virus. As a result of our interest in the use of electric
current to alter biological systems, we focused our investigations on the
ability of direct electrical current at biocompatible levels to alter the
infectivity of HIV for susceptible CD4 positive cells in vitro. MATERIAL AND METHODS Electrical Treatment of HIV The RF strain of HIV (AIDS Reagent Program) was cryopreserved prior to treatment at -70 degrees C. For treatment, a sample of virus was thawed and maintained on ice at 4 degrees C. Ten microliters (uL) of HIV at a concentration of 10 sup.5 infectious particles per mL were placed into a chamber which included a pair of platinum electrodes 1mm apart permanently mounted into a well 1.56 mm in length and 8.32 mm in depth equal to 12.9uL volume capacity. The chamber was connected to a power supply capable of creating constant direct current. The viral aliquots were exposed to direct currents ranging form 0 micro amperes (uA) for up to 12 minutes to 100UA for up to 6 minutes. Intermediate currents of 25, 50, and 75 uA were used to expose similar viral aliquots. Under these conditions, for example, 0, 50, and 100 uA represent 0, 3.85, and 7.7 uA/mm sup.2 current densities respectively. The current was monitored throughout the experiment. A matrix of current and time employed is shown in Table 1.
After the exposure of virus to electric current, the contents of the chamber were removed and placed into sterile micro tubes. Five uL of each sample were removed and diluted with 95 uL tissue culture medium supplemented with 10% fetal calf serum (FCS) for subsequent assays. Syncytium-Formation Assay This assay was performed as previously described by Nara et al. Briefly, 10 sup.5 CEM-SS cells were dispensed into poly-L-lysine coated microtiter wells. Thereafter, tenfold dilutions of H9 cells incubated with the treated HIV samples were co-cultured in triplicate for up to 4 days with the CEM-SS cells. Identical wells were prepared with control uninfected and infected cells. The wells were examined for syncytium formation at 2 and 3 days and quantified using an inverted microscope. Reverse Transcriptase Assay Uninfected H9 cells were pelleted at 1,000 rpm for 5 minutes at room temperature, the supernatant was decanted, and the cells were resuspended in 100 uL treated viral sample. The cells were incubated for up to 6 hours with the viral samples. At the end of the incubation time,. the viral/cell suspensions were centrifuged at 1,000 rpm for 5 minutes and the supernatant decanted. The cell pellet was then resuspended in 5mL of RPMI, 10% FCS and placed into a T25 tissue culture flask and maintained at 37 degrees C, 5% COsub.2 in a humidified chamber. At 2 day intervals (beginning at day 2), 1 mL of the cell suspensions was removed from each sample and centrifuged at 1,000 rpm for 5 minutes in order to pellet the cells. The supernatant was subsequently centrifuged at 14,000 rpm for 15 minutes. the pellet was resuspended in suspension buffer and assayed using standard methodology employing Mg++ as the divalent cation, poly (rA) oligo d(T) 12-18 as template primer, and tritiated thymidine (sup.3H-TdR) which comprise the reaction mixture. Known HIV positive and negative control samples were included in each assay for reference. Thirty uL of the reaction mixture were added to each 10 uL viral sample and incubated at 37 degrees C for 60 min. Samples were then incubated with 1uL of cold quench solution on ice for 15 minutes and filtered through a Millipore manifold. Chimneys were rinsed first with wash solution and followed by cold 95% ethanol. The filters were dried by vacuum and counted in scintillation fluid. Reverse transcriptase activity is expressed as counts per minute (cpm) and is considered positive only if cpm are at least five times greater than cpm obtained with HIV-negative control samples. Biocompatibility of Electric Currents/Time To determine if the electric currents used were in a biocompatible range of energy, uninfected H9 cells were exposed to distinct currents for different amounts of time. The H9 cells were washed two times in Hanks Balance Salt Solution (HBSS). Thereafter, the cells were resuspended in RPMI, 10% FCS at a concentration of 10sup.(?) cells per mL. Ten uL of the cell samples were placed into the reaction chamber. The cell samples were then exposed to 0, 50, or 100 uA for 0, 3, or 6 minutes. At the end of each test, the cell sample was removed from the chamber and approximately 10 uL of the sample was mixed with 90 uL of tyrpan blue. The number of viable cells was determined by trypan blue exclusion using a hemocytometer and light microscope. Results are expressed as percentage of viable cells from the total of all cells. At least 200 cells per field were counted. Statistical Analysis Results of the syncytium-formation and reverse transcriptase assays were tested for statistical significance by the Student's t test and analyses of variance. RESULTS Syncytium-Formation Assay Using this index of HIV infectivity, it was determined that exposing virus to direct electric current suppressed its capacity to induce the formation of syncytia. Figure 1 shows a representative experiment and Table 2 shows the group data for three separate experiments. As can be noted in Figure 1, a statistically significant (p<0.001) reduction in syncytium number was observed, and this reduction was dependent upon the current applied to the viral isolate. At three different viral dilutions, there were analogous results in that a total charge of 200 uA x min (25uA for 8 minutes) reduced the number of syncytia from 50% to 65% while a charge of 300 uA x min (50uA for 6 minutes, 75 uA for 4 minutes, or 100uA for 3 minutes) resulted in 90% reduction. 2 illustrations here Reverse Transcriptase Assays
The direct electric currents to which HIV was exposed also reduced reverse transcriptase activity. Five separate experiments were conducted; a representative experiment is shown in Figure 2 and the group data are included in Table 3. As can be seen in Figure 2, there was a significant decrease in the amount of reverse transcriptase activity after exposure of the virus to either 50 uA for 3 or 6 minutes . An equivalent reduction in reverse transcriptase activity was also noted with exposure to 100 uA for 3 minutes. and near ablation of reverse transcriptase activity was seen with exposure of the viral isolate to 100uA for 6 minutes resulted in a 94% reduction. An analysis of variance indicates that the decrease in reverse transcriptase activity was statistically significant (p<0.001).
Biocompatibility of Electric Currents/Time 1 illustration here The ------(?) of a viability analysis using trypan blue exclusion criteria applied to uninfected cells exposed to the different currents and times used for these studies are shown in Table 4. The viability of H9 cells, after exposure to 100uA for either 3 or 6 minutes, did not show a significant decrease when compared to the 0 current control. After maximum treatment at 100 uA for 6 minutes, cell viability was 93% . Interestingly, in other preliminary experiments in which HIV-infected H9 cells were used, the results show that at 100 uA there may have been a significant decrease in the number of viable cells. That is, while an instantaneous pulse of 100 uA did not affect the viability of infected cells, a decrease in viability was noted at 3 and 6 minutes of exposure to 100 uA. This decrease was time-dependent in that exposure to 100 uA for 3 minutes resulted in a viability of 83% while 100 uA for 6 miutes resulted in a viability of 80%. Although theses data are provocative, they only represent a preliminary experiment and require further investigation.
With respect to the possibility that the electric current was transduced into heat, the calculated rise in termperature within the chamber was determined to be less than 1 degree C. In order to verify this, a temperature microprobe was introduced into the chamber containing tissue culture medium alone. Results of these studies are shown in Table 5. Similar results were obtained when H9 cell-containing medium was placed in the reaction chamber. The data indicate that for the currents and times used for these experiments, there was no alternation in the temperature of the chamber.
The results repored here demonstrate that HIV treated with direct electric currents from 50 to 100 uA has a significantly reduced infectivity for susceptible cells in vitro. This reduction of infectivity correlates with the total electric charge passing through the chamber. Although extrapolation of these data predicts that ablation of HIV infectivity may be possible, and additional preliminary data support this prediction, the expectation that some virions may still excape the electrical effect cannot be discounted. Nevertheless, the therapeutic potential of electric current may reside in its ability to lower the viral titer to subclinical significance or in its incorporation into a strategy analogous to that of other therapies in which repeated cycles of treatment eventually achieve remission or cure. The data presented in this report are based on both quantitative and quantal determinations of viral infectivity. Although the syncytium-formation assay can be used to quantify the number of infectious viral particles, this use with respect to HIV may be abridged because of the ability of free fusigenic peptide (gp41) to induce syncytia by itself. Therefore, while syncytia were observed at some dilutions of electrically treated virus, this may simply represent the presence of soluble gp41 in the tissue culture medium. We believe that the correlation between total charge and reduction in syncytium number more adequately reflects the ability of direct electric current to reduce HIV infectivity. This belief is also suported by the results of the reverse transcriptase assays. Although a decrease in HIV reverse transcriptase does not assure reduced infectiousness of this virus for susceptible cells, we feel that, taken together with the syncytium-formation data, the results indicate that significant attenuation of HIV infectivity is achieved by treatment with direct electric currents. With respect to the biocompatibility of the electric currents and toal charges reported here, two separate sets of evidence are applicable. The first has to do with the results showing that, by trypan blue exclusion, no significant cytotoxicity was induced in H9 cells by any total charge tested. The other evidence is obtained from reports which clearly indicate that the amount of electricity used for these experimetns is significantly below presently used therapeutic electric curents which are in the milliampere range. Rather than negative effects, exposure of cells to electric current may actually have positive consequences for resistance to infection in that important cellular electrochemical changes correlate with enhancement of specific enzymatic activities. In particular, a facilitation of succinate dehydrogenase (SDH) and ATPase activity has been observed. Both of these enzymes are associated with the oxidative capacity of the cell. Specifically, it has been suggested that an electrochemical reaction occurs between mitochondrial membrane-bound H+ ATPase and ADP leading to the formation of ATP. Therefore, exposure of cells to direct electrric currrent may directly or indirectly increase energy resources within a cell and facilitate cell metabolism. This, in turn, may actually render a cell less susceptible to the effects of viral infection. In summary, the data presented here indicate that biocompatible direct electric current significantly reduces the infectivity of HIV. Continuing investigations are exploring the mechanisms through which this effect is mediated. The initial focus of these experiments is centered on the potential role which ionic and molecular species generated by electrolysis may have on the virus. However, the complete mechanism by which direct electric current attenuates HIV infectivity is undoubtedly far more complex than simple electrolysis. Nonetheless, and independent of a complete understanding of all of the mechanisms involved in the attenuation of HIV infectivity, the present observations may serve as an initial step for the development of new strategies to treat infection or prevent transmission of HIV through the treatment of the blood supply. ACKNOWLEDGEMENT The authors wish to thank Mrs. Barbara Shea for her excellent secretarial assistaince and Dr. Gabor Kemeny for important technical help. (STI) REFERENCES 1. Sato PA, Chin J, Mann JM. REview of AIDS and HIV infection: global epidemiology and statistics. AIDS 1989; 3 Suppl; 1:S301-7. 2. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987'1 Supp 36:S1-15. 3. Thacker SB, Berkleman RI, Public health surveillance in the United States. Epidemiol Rev. 1988"10:164-90. 4. Klein RS, Friedland GH. Transmission of human immunodeficiency virus type 1 (HIV) by exposure to blood: defining the risk. Ann Int Med 1990; 113:729-30. 5. Oxtoby MJ. Epidemiology of pediatric AIDS in the UNited States. In: Kozlowski PB, Snider DA, Vietze PM, et al, ads. Brain in pediatric AIDS; 1990. p 1-8 6. Broder S, Mitsuya H, Yarchoan R, et al. Antiretroviral therapy in AIDS. Ann Int Med 1990; 113:604-18. 7. Perno CF, Baseler MW, Broder S, et al. Infection of monocytes by human immunodeficiency virus I blocked by inhibitors of CD4-gp 120 binding, even in the presence of enhancing antibiodies. J Exp Med 1990; 171:1043-56. 8. Mitsuya, H, Weinhold KJ, Furman FA, et al. 3'- Azido-3'-deoxythymidine (BW A509U): an ativiral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Proc Natl Acad Sci USA 1985; 82:7096-100. 9. Quinnan GV, Wells MA, Wittek AE, et al. INactivation of human T-cell virus, type III by heat, chemicals and irradiation. TRansfusion 1986;26:481-3. 10. Bisaccia E, Berger C, Kainer AS. Extracorporeal photopheresis in the treatment of AIDS-related complex: a pilot sutdy. Ann Int Med 1990;113:270-75. 11. Nara PL, Hatch WC, Dunlop NM, et al. Simple, rapid quantitative, syncytiumforming microassay for the detection of human immunodeficiency virus neutralizing antibody. AIDS Res Hum Retrovirus 1987;3:283-302. 12. Cheng N, VanHoof H, Bockx E, et al. The effects of electric currents on ATP generation, protein synthesis, and membrane transport in rat skin. Clin Ortho Rel Res 1983;175:263-72. 13. Frank C, Schachar N, Dittrich D, et al. Electromagnetic stimulation of ligament healing in rabbits. Clin Ortho Rel Res 1983;175:263-72. 14. Eriksson E, Hagg,arl T. comparisom opf isometric muscle training and electrical stimulation supplementing isometric muscle training in the recovery after major knee ligament surgery. Amer J Sports Med 1979;7:169-71. 15. Stanish WD, Valiant GA, Bonen A, et al. The effects of immobilization and of electrical stimulation on muscle glycogen and myofibrillar ATPase. Can J Appl Sport Sc 1982;7:267-71 16. Pilla AA. Electrochemical information transfer at living cell membranes. Ann NY Acad Sci 1974;205:148-70.
|
